Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
EXOSC7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC6 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC6, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOSC1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOSC1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOG Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOG, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC7 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC7, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC6B Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC6B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC6 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC6, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.